2019
Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018
AHMED, Niaz; Heinrich AUDEBERT; Guillaume TURC; Charlotte CORDONNIER; Hanne CHRISTENSEN et al.Základní údaje
Originální název
Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018
Autoři
AHMED, Niaz; Heinrich AUDEBERT; Guillaume TURC; Charlotte CORDONNIER; Hanne CHRISTENSEN; Simona SACCO; Else Charlotte SANDSET; George NTAIOS; Andreas CHARIDIMOU; Danilo TONI; Christian PRISTIPINO; Martin KOHRMANN; Joji B. KURAMATSU; Geotz THOMALLA; Robert MIKULÍK; Gary A. FORD; Joan MARTI-FABREGAS; Urs FISCHER; Magnus THOREN; Erik LUNDSTROM; Gabriel J. E. RINKEL; H. Bart VAN DER WORP; Marius MATUSEVICIUS; Georgios TSIVGOULIS; Haralampos MILIONIS; Marta RUBIERA; Robert HART; Tiago MOREIRA; Maria LANTZ; Christina SJOSTRAND; Grethe ANDERSEN; Peter SCHELLINGER; Konstantinos KOSTULAS; Katharina Stibrant SUNNERHAGEN; Boris KESELMAN; Eleni KOROMPOKI; Jan PURRUCKER; Pooja KHATRI; William WHITELEY; Eivind BERGE; Michael MAZYA; Diederik W. J. DIPPEL; Satu MUSTANOJA; Mads RASMUSSEN; Asa Kuntze SODERQVIST; Irene ESCUDERO-MARTINEZ a Thorsten STEINER
Vydání
EUROPEAN STROKE JOURNAL, LONDON, SAGE PUBLICATIONS LTD, 2019, 2396-9873
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30210 Clinical neurology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/19:00112987
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Stroke; thrombolysis; thrombectomy; oral anticoagulation; patent foramen ovale; prehospital; intracerebral haemorrhage; ischaemic stroke
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 18. 2. 2020 11:55, Mgr. Tereza Miškechová
Anotace
V originále
The purpose of the European Stroke Organisation-Karolinska Stroke Update Conference is to provide updates on recent stroke therapy research and to give an opportunity for the participants to discuss how these results may be implemented into clinical routine. The meeting started 22 years ago as Karolinska Stroke Update, but since 2014 it is a joint conference with European Stroke Organisation. Importantly, it provides a platform for discussion on the European Stroke Organisation guidelines process and on recommendations to the European Stroke Organisation guidelines committee on specific topics. By this, it adds a direct influence from stroke professionals otherwise not involved in committees and work groups on the guideline procedure. The discussions at the conference may also inspire new guidelines when motivated. The topics raised at the meeting are selected by the scientific programme committee mainly based on recent important scientific publications. This year's European Stroke Organisation-Karolinska Stroke Update Meeting was held in Stockholm on 11-13 November 2018. There were 11 scientific sessions discussed in the meeting including two short sessions. Each session except the short sessions produced a consensus statement (Full version with background, issues, conclusions and references are published as web-material and at and ) and recommendations which were prepared by a writing committee consisting of session chair(s), scientific secretary and speakers. These statements were presented to the 250 participants of the meeting. In the open meeting, general participants commented on the consensus statement and recommendations and the final document were adjusted based on the discussion from the general participants Recommendations (grade of evidence) were graded according to the 1998 Karolinska Stroke Update meeting with regard to the strength of evidence. Grade A Evidence: Strong support from randomised controlled trials and statistical reviews (at least one randomised controlled trial plus one statistical review). Grade B Evidence: Support from randomised controlled trials and statistical reviews (one randomised controlled trial or one statistical review). Grade C Evidence: No reasonable support from randomised controlled trials, recommendations based on small randomised and/or non-randomised controlled trials evidence.